Joke Van Den Berg

Therapeutic efficacy of a respiratory syncytial virus fusion inhibitor

Dirk Roymans, Sarhad Alnajjar, Michael B. Battles et al. · Nature Communications · 2017 · 97 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +17

Impact of the Interaction of R207910 with Rifampin on the Treatment of Tuberculosis Studied in the Mouse Model

Nacer Lounis, Tom Gevers, Joke Van Den Berg et al. · Antimicrobial Agents and Chemotherapy · 2008 · 61 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

ATP Synthase Inhibition of <i>Mycobacterium avium</i> Is Not Bactericidal

Nacer Lounis, Tom Gevers, Joke Van Den Berg et al. · Antimicrobial Agents and Chemotherapy · 2009 · 50 citations · Full text

Medicine, Microbiology, Pharmacology +17

Prevention of Drug Carryover Effects in Studies Assessing Antimycobacterial Efficacy of TMC207

Nacer Lounis, Tom Gevers, Joke Van Den Berg et al. · Journal of Clinical Microbiology · 2008 · 39 citations · Full text

Life Sciences, Microbiology, Pharmacology +14

Discovery of 3-({5-Chloro-1-[3-(methylsulfonyl)propyl]-1<i>H</i>-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-2-one (JNJ-53718678), a Potent and Orally Bioavailable Fusion Inhibitor of Respiratory Syncytial Virus

Sandrine Vendeville, Abdellah Tahri, Lili Hu et al. · Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16